Correlation Between Lantern Pharma and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Lantern Pharma and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantern Pharma and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lantern Pharma and Coya Therapeutics, Common, you can compare the effects of market volatilities on Lantern Pharma and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantern Pharma with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantern Pharma and Coya Therapeutics,.
Diversification Opportunities for Lantern Pharma and Coya Therapeutics,
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lantern and Coya is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Lantern Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantern Pharma are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Lantern Pharma i.e., Lantern Pharma and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between Lantern Pharma and Coya Therapeutics,
Given the investment horizon of 90 days Lantern Pharma is expected to generate 0.69 times more return on investment than Coya Therapeutics,. However, Lantern Pharma is 1.45 times less risky than Coya Therapeutics,. It trades about -0.14 of its potential returns per unit of risk. Coya Therapeutics, Common is currently generating about -0.25 per unit of risk. If you would invest 366.00 in Lantern Pharma on August 29, 2024 and sell it today you would lose (59.00) from holding Lantern Pharma or give up 16.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lantern Pharma vs. Coya Therapeutics, Common
Performance |
| Timeline |
| Lantern Pharma |
| Coya Therapeutics, Common |
Lantern Pharma and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lantern Pharma and Coya Therapeutics,
The main advantage of trading using opposite Lantern Pharma and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantern Pharma position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.| Lantern Pharma vs. Tff Pharmaceuticals | Lantern Pharma vs. Generation Bio Co | Lantern Pharma vs. Lyra Therapeutics | Lantern Pharma vs. Immunome |
| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |